Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 93 for

Edit search filters
  1. Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

    Jacksonville, FL

  2. Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension

    Rochester, MN

  3. A Biorepository to Study Portopulmonary Hypertension

    Rochester, MN

  4. Systolic Pressure Intervention Trial Factors Affecting Atherosclerosis Study

    Jacksonville, FL

  5. A Study to Develop a Pulmonary Hypertension Association Registry (PHAR)

    Rochester, MN

  6. U.S. CTEPH Registry

    Jacksonville, FL

  7. A Study to Assess Quality of Life with the PAH SYMPACT Questionnaire in the Pulmonary Hypertension Clinic

    Rochester, MN

  8. National Biological Sample and Data Repository for Pulmonary Arterial Hypertension

    Jacksonville, FL

  9. A Study to Evaluate Pulmonary Vascular Complications of Liver Disease 3 (PVCLD3)

    Rochester, MN

  10. Pulmonary Hypertension Association Registry

    Rochester, MN

.

Mayo Clinic Footer